54 related articles for article (PubMed ID: 31325449)
1. Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB
Karwad MA; Couch DG; Wright KL; Tufarelli C; Larvin M; Lund J; O'Sullivan SE
Biochem Pharmacol; 2019 Oct; 168():465-472. PubMed ID: 31325449
[TBL] [Abstract][Full Text] [Related]
2. FABP5 deletion in nociceptors augments endocannabinoid signaling and suppresses TRPV1 sensitization and inflammatory pain.
Bogdan DM; Studholme K; DiBua A; Gordon C; Kanjiya MP; Yu M; Puopolo M; Kaczocha M
Sci Rep; 2022 Jun; 12(1):9241. PubMed ID: 35655086
[TBL] [Abstract][Full Text] [Related]
3. The evolution and comparative neurobiology of endocannabinoid signalling.
Elphick MR
Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3201-15. PubMed ID: 23108540
[TBL] [Abstract][Full Text] [Related]
4. Interactions between CB(1) receptors and TRPV1 channels mediated by 12-HPETE are cytotoxic to mesencephalic dopaminergic neurons.
Kim SR; Bok E; Chung YC; Chung ES; Jin BK
Br J Pharmacol; 2008 Sep; 155(2):253-64. PubMed ID: 18552868
[TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption.
Ding W; Yang L; Shi E; Kim B; Low S; Hu K; Gao L; Chen P; Ding W; Borsook D; Luo A; Choi JH; Wang C; Akeju O; Yang J; Ran C; Schreiber KL; Mao J; Chen Q; Feng G; Shen S
Nat Commun; 2023 Oct; 14(1):6696. PubMed ID: 37880241
[TBL] [Abstract][Full Text] [Related]
6. Downstream effects of endocannabinoid on blood cells: implications for health and disease.
Gasperi V; Evangelista D; Savini I; Del Principe D; Avigliano L; Maccarrone M; Catani MV
Cell Mol Life Sci; 2015 Sep; 72(17):3235-52. PubMed ID: 25957591
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids and the expanded endocannabinoid system in neurological disorders.
Cristino L; Bisogno T; Di Marzo V
Nat Rev Neurol; 2020 Jan; 16(1):9-29. PubMed ID: 31831863
[TBL] [Abstract][Full Text] [Related]
8. A Closer Look at Anandamide Interaction With TRPV1.
Muller C; Lynch DL; Hurst DP; Reggio PH
Front Mol Biosci; 2020; 7():144. PubMed ID: 32793630
[TBL] [Abstract][Full Text] [Related]
9. The TRPV1 channel regulates glucose metabolism.
Page AJ; Hatzinikolas G; Vincent AD; Cavuoto P; Wittert GA
Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E667-E676. PubMed ID: 31408376
[TBL] [Abstract][Full Text] [Related]
10. Aryl hydrocarbon receptor utilises cellular zinc signals to maintain the gut epithelial barrier.
Hu XL; Xiao W; Lei Y; Green A; Lee X; Maradana MR; Gao Y; Xie X; Wang R; Chennell G; Basson MA; Kille P; Maret W; Bewick GA; Zhou Y; Hogstrand C
Nat Commun; 2023 Sep; 14(1):5431. PubMed ID: 37669965
[TBL] [Abstract][Full Text] [Related]
11. Anti-Obesity Potential through Regulation of Carbohydrate Uptake and Gene Expression in Intestinal Epithelial Cells by the Probiotic
Park SY; Choi JW; Oh DN; Lee EJ; Kim DP; Yoon SJ; Jang WJ; Han SJ; Lee S; Lee JM
J Microbiol Biotechnol; 2023 May; 33(5):621-633. PubMed ID: 36864459
[TBL] [Abstract][Full Text] [Related]
12. The PPARα Regulation of the Gut Physiology in Regard to Interaction with Microbiota, Intestinal Immunity, Metabolism, and Permeability.
Grabacka M; Płonka PM; Pierzchalska M
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430628
[TBL] [Abstract][Full Text] [Related]
13. The Microbiome and Gut Endocannabinoid System in the Regulation of Stress Responses and Metabolism.
Srivastava RK; Lutz B; Ruiz de Azua I
Front Cell Neurosci; 2022; 16():867267. PubMed ID: 35634468
[TBL] [Abstract][Full Text] [Related]
14. The Endocannabinoid System and Physical Activity-A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders.
Charytoniuk T; Zywno H; Berk K; Bzdega W; Kolakowski A; Chabowski A; Konstantynowicz-Nowicka K
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328503
[TBL] [Abstract][Full Text] [Related]
15. Sex Differences in a Rat Model of Peripheral Neuropathic Pain and Associated Levels of Endogenous Cannabinoid Ligands.
Boullon L; Finn DP; Llorente-Berzal Á
Front Pain Res (Lausanne); 2021; 2():673638. PubMed ID: 35295501
[TBL] [Abstract][Full Text] [Related]
16. Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint.
Schiano Moriello A; Di Marzo V; Petrosino S
Animals (Basel); 2022 Jan; 12(3):. PubMed ID: 35158670
[TBL] [Abstract][Full Text] [Related]
17. Receptor-targeted nanoparticles modulate cannabinoid anticancer activity through delayed cell internalization.
Durán-Lobato M; Álvarez-Fuentes J; Fernández-Arévalo M; Martín-Banderas L
Sci Rep; 2022 Jan; 12(1):1297. PubMed ID: 35079042
[TBL] [Abstract][Full Text] [Related]
18. The Biosynthesis and Metabolism of the
Bhandari S; Bisht KS; Merkler DJ
Front Mol Biosci; 2021; 8():801749. PubMed ID: 35047560
[TBL] [Abstract][Full Text] [Related]
19. On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence.
Paredes-Ruiz KJ; Chavira-Ramos K; Orozco-Morales M; Karasu C; Tinkov AA; Aschner M; Santamaría A; Colín-González AL
Neurotox Res; 2021 Dec; 39(6):2072-2097. PubMed ID: 34741755
[TBL] [Abstract][Full Text] [Related]
20. The Peripheral Cannabinoid Receptor Type 1 (CB
O'Sullivan SE; Yates AS; Porter RK
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
